- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: New HealthCare.gov Site More User Friendly
What we're reading, October 27, 2015: a much-improved Healthcare.gov website, report says drug prices rose at a much slower rate in 2015, and USPSTF recommends glucose testing in asymptomatic adults who are overweight or obese.
Newly Remodeled HealthCare.gov Site More User Friendly
The new website, reports The New York Times, has worked as the government promised, during the third open enrollment season. A new feature this year is a cost calculator that helps would-be enrollees compare different health plans based on their estimate of low, medium, of high use of medical services in 2016, though it does not let users sort plans based on total costs.
Read more here: http://nyti.ms/1k73ejo.
2015 Sees a More Gradual Slope to Prescription Drug Prices
A new analysis by the healthcare technology firm Truveris, reports that prescription drug prices rose 9.1% through September 30, 2015, for all medicines, compared with 10.9% seen in 2014. This information is based on the company’s analysis of claims data that included more than 300 million prescription payments to US pharmacies. The claims data does not account for drug rebates, coupons, or copay cards.
Read more here: http://bit.ly/208u4bH.
USPSTF Recommends Screening for Glucose and T2DM in Overweight and Obese Adults
The U.S. Preventive Services Task Force (USPSTF), as part of cardiovascular risk assessment in obese and overweight adults 40 to 70 years of age, has recommended screening for blood glucose levels. Additionally, the USPSTF recommendation urges physicians to refer patients with abnormal glucose levels to behavior counseling to ensure a healthy diet and incorporating physical activity in their daily life.
Read the paper published in the Annals of Internal Medicine here: http://bit.ly/1N38TCJ.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
